Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PDFE-2304
- Development stage
- Phase 2
- Lead developer
- PDFE Pharma Innovations
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
PDFE-2304 is a topical solution developed by PDFE Pharma Innovations FZCO. It is currently being investigated in clinical trials for the treatment of Androgenic Alopecia (AGA), where its safety and efficacy are being compared against Minoxidil 5% Topical Solution.
Beyond the preview
Go deeper on PDFE-2304.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PDFE-2304.